Results 151 to 160 of about 82,941 (302)

Differentiation of triple-negative breast cancer and benign breast lesions using multiparametric ultrasonography

open access: yesJournal of Ultrasonography
Assessment of features of triple-negative breast cancer (TNBC) and benign breast lesions in multipara-metric ultrasonography, with an emphasis on the added value of sonoelastography.
Gumowska Magdalena   +1 more
doaj   +1 more source

The Role of Primary Tumor Resection in De Novo Bone‐Only Metastatic Breast Cancer: A Propensity Score‐Matched Analysis

open access: yesJournal of Surgical Oncology, EarlyView.
ABSTRACT Objective To evaluate the impact of primary tumor resection (PTR) on overall survival (OS) and cancer‐specific survival (CSS) in women with de novo bone‐only metastatic breast cancer (MBC). Methods Women diagnosed with de novo bone‐only metastatic breast cancer between 2010 and 2017 were identified from the Surveillance, Epidemiology, and End ...
Bin Wang   +7 more
wiley   +1 more source

Loss of immunosurveillance in TNBC.

open access: yes
This paper describes cardinal changes in innate and adaptive immunity and natural killer cell function in TNBC. We previously described other aspects of immunodeficiency in TNBC including deficiency in IL2RG.
openaire   +3 more sources

Circ_0006174 Drives Triple Negative Breast Cancer Progression and Immune Escape Through Regulating miR‐3139/PD‐L1 Axis

open access: yesThe Kaohsiung Journal of Medical Sciences, EarlyView.
ABSTRACT Triple‐negative breast cancer (TNBC) is characterized as an aggressive malignancy with limited therapeutic options. The circular RNA circ_0006174 has been implicated in oncogenic processes across various cancers; however, its specific role in the pathogenesis of TNBC remains unclear.
Yong‐Zhe Tang   +4 more
wiley   +1 more source

Preclinical PET imaging of glycoprotein non-metastatic melanoma B in triple negative breast cancer: Feasibility of an antibody-based companion diagnostic agent [PDF]

open access: yes, 2017
Dehdashti, Farrokh   +12 more
core   +2 more sources

Risk Factors Influencing Efficacy and Prognosis Evaluation of Neoadjuvant Systemic Therapy in Triple‐Positive Breast Cancer

open access: yesThe Kaohsiung Journal of Medical Sciences, EarlyView.
ABSTRACT To identify the determinants of the response to neoadjuvant systemic therapy (NST) in triple‐positive breast cancer (TPBC), we retrospectively enrolled 520 patients with human epidermal growth factor receptor 2 (HER2)‐positive breast cancer who were treated at The First Affiliated Hospital of Chongqing Medical University between January 2015 ...
Lin‐Rui Miao   +7 more
wiley   +1 more source

Statins & TNBC

open access: yesOncology Times, 2021
openaire   +2 more sources

Data‐Independent Acquisition Mass Spectrometry in Tumor Classification and Cancer Biomarker Research

open access: yesMass Spectrometry Reviews, EarlyView.
Abstract Cancer treatment is far from optimal also because current classification systems do not reflect the complex molecular status of the tumor and its phenotype in sufficient detail. To construct molecular tumor classifiers, omics tools provide complex molecular data reflecting many aspects from genotype to phenotype.
Jan Simonik   +3 more
wiley   +1 more source

Topological analysis of the human lymph node reticular network predicts outcome in breast cancer

open access: yesThe Journal of Pathology, EarlyView.
Abstract Axillary LNs (ALNs) initiate immune responses in breast cancer (BC) but how and when ALNs become dysfunctional, facilitating metastasis, is unclear. The fibroblastic reticular cell (FRC) network within ALNs provides structural support and mediates immune homeostasis, but we have yet to elucidate whether this network changes during BC ...
Amy M Llewellyn   +7 more
wiley   +1 more source

Proteomic Characterization of AS1411 Reveals ATP6AP1 as a Mediator of Triple‐Negative Breast Cancer Progression

open access: yesPROTEOMICS, EarlyView.
ABSTRACT Triple‐negative breast cancer (TNBC) is an aggressive subtype of breast cancer characterized by high metastatic potential, poor prognosis, and limited effective therapeutic options. In this study, we investigated the molecular mechanisms underlying the anticancer effects of the nucleolin (NCL)‐targeting DNA aptamer AS1411 using label‐free ...
Ha‐Song Bae   +6 more
wiley   +1 more source

Home - About - Disclaimer - Privacy